The Galien Foundation
medal
Join us

    The Galien Foundation
      Prix Galien Medal
      Join us
      Prix Galien Coin
      Join us
      Galien Forum Logo
      weeks
      +
      days
      Galien_ForumUSA2026_white

      Legacy & Leap: Hindsight, Foresight, and a Generation's Impact on Health Innovation

      Thursday Oct. 29, 2026

       VENUE  
      NEW YORK ACADEMY OF MEDICINE
      7:30 AM - 5 PM

      Register now
      Revisit the 2025 Edition

      950

      C-LEVEL PARTICIPANTS

      125

      COMPANIES

      90

      INSTITUTIONS/
      ACADEMICS

      * Based on 2025

      Galien Forum
      Galien Forum Logo
      Galien Forum Logo

      Thursday Oct. 26, 2023

      Science Meets Society:

      Balancing Innovation, Equity and Public Health in a Post-Covid World

      Read the abstract
      Mask Group 163

      The Galien Forum, hosted this year at the New York Academy of Medicine, provides an entire day of lively discussions featuring Nobel Laureates, prominent policymakers, and top industry leaders who share insights on the most pressing health issues of our era, while showcasing the newest research and clinical approaches to diagnosis, treatment, and cure.

      In tandem with the Forum, the second annual Galien Patient Summit will bring together patient groups, key thought leaders, regulators and industry to evaluate challenges through the patient prism.

      Don’t miss the debates!

      Forum 2025 room

      In the program Galien Forum 2023

      Thursday Oct. 26, 2023

      Preliminary Program

      PANEL 1

      Breakthroughs & Blind Spots:
      What Will Today’s Consensus Regret Tomorrow?

      PANEL 2

      Medical Triumph vs Pricing Paradox:
      Can We Afford the Medicines We’re Capable of Creating?

      PANEL 3

      20 Years in 20 Minutes:
      A History of Breakthroughs + Lessons for the Next 2 Decades

      PANEL 4

      The Biology We Still Don’t Understand:
      Frontiers That Will Define the Next 20 Years

      PANEL 5

      Life Science Diplomacy & Scientific Sovereignty:
      Strategy for the Next 20 Years

      PANEL 6 I CEO PANEL

      Biopharma Leaders:
      Leading the Leap

      FIRESIDE CHAT

      FDA Commissioner
      (1 Year Later)

      PANEL 7

      The Science Trust Conundrum:
      When Society Doubts Its Own Progress

      Galien Forum Logo
      PANEL 1
      Promise & Reality:
      Decoding AI’s Impact on Drug Development
      Galien Forum Logo

      PANEL 2 
      Advancing the Pipeline:
      Ensuring Academic and Government Discoveries are Translated for Medical Impact

      Mental Health in America
      PANEL 3 
      Therapeutic Area Advances and Challenges (mRNA & CRISPR): Getting Gene Therapy Innovation to a Critical Mass of Patients
      Fireside with J&J’s Alex Gorsky
      FIRESIDE CHAT 
      Fireside Chat with Alex Gorsky
      AI, Digital Health and Clinical Trials

      PANEL 4a 
      AI's Impact on Personal and Public Health -- Now & in the Future

      PANEL OBESITY SCIENCE (1)

      PANEL 4b 
      Advancing Brain Health: Innovations and Insights for a Healthier Future

      Fireside with J&J’s Alex Gorsky
      CEO PANEL

      How to Build a Paradigm-Transforming Blockbuster

      Who will be speaking in 2026

      Partial list as of March 23, 2026

      Bruce Booth-1

      Bruce Booth

      Partner, Atlas Venture

      Albert Bourla Photo

      Albert Bourla

      Chairman & CEO, Pfizer

      Pr. Awa Marie COLL SECK, MD, PhD

      Awa Coll Seck

      Former Minister of Health, Senegal; Chair of Prix Galien Africa Committee

      Howard Chang

      Howard Chang

      Senior Vice President, Global Research & CSO, Amgen

      crowley_john

      John F. Crowley

      President & CEO, Biotechnology Innovation Organization (BIO)

      Robert M. Davis-1 Image

      Robert M. Davis

      Chairman and CEO, Merck & Co., Inc
      Sue Desmond-Hellmann

      Sue Desmond-Hellman

      Former CEO, Gates Foundation; Former Chancellor, UCSF

      Samantha Du

      Samantha Du

      Co-founder & CEO, Zai Lab

      Joaquin Duato

      Joaquin Duato

      Chairman & CEO, Johnson & Johnson

      ⁠Kenneth C. Frazier Image

      Ken Frazier

      Prix Galien USA Committee Chair; Retired Chairman & CEO, Merck & Co., Inc.; Chairman, Health Assurance Initiatives, General Catalyst

      Yvonne Greenstreet

      Yvonne Greenstreet

      Chair & CEO, Alnylam

      Atul A. Gawande

      Atul A. Gawande

      Fish Chair in Surgery, Brigham and Women’s Hospital; Samuel O. Thier Professor of the Practice, Harvard Medical School; Distinguished Professor in Residence, Ariadne Labs

      Avram Hershko-1

      Avram Hershko

      Nobel Laureate, Distinguished Professor, Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa

      Katherine High

      Katherine High

      CEO, RhyGaze

      Larry Jameson

      Larry Jameson

      President, University of Pennsylvania

      Eric Lander

      Eric Lander

      Founding Director Emeritus & Core Institute Member, Broad Institute of MIT & Harvard

      Olivier Laureau

      Olivier Laureau

      Chairman and CEO, Servier Group & Servier International Foundation for Research

      Nick Leschly

      Nick Leschly

      Founder & CEO,  Atida Bio; Co-Founder & Chair, Altido Therapeutics; Former CEO, bluebird bio

      Jeremy Levin

      Jeremy Levin

      Executive Chairman, Ovid Therapeutics; Former Chair, BIO

      Brett Monia,

      Brett Monia

      CEO, Ionis Pharmaceuticals

      Alex Oshmyansky

      Alex Oshmyansky

      CEO & Co-Founder, Mark Cuban Cost Plus Drug Company

      Paulsen

      Jean Frederic Paulsen

      Chairman & CEO, Ferring Pharmaceuticals

      Andrew Plump

      Andrew Plump

      President, Research & Development, Takeda

      Vardit Ravitsky

      Vardit Ravitsky

      President and CEO, The Hastings Center for Bioethics

      Michael Rosenblatt Photo

      Michael Rosenblatt

      Chair of Prix Galien USA Committee, Member, Harvard Board of Overseers

      ⁠Thomas Schinecker Photo

      Thomas Schinecker

      Chairman & CEO, Roche

      ⁠Marc Tessier-Lavigne Photo

      Marc Tessier-Lavigne

      CEO, Xaira Therapeutics; President Emeritus, Stanford

       

      Helen Torley

      Helen Torley

      President & CEO, Halozyme Therapeutics

      Renee Wegrzyn

      Renee Wegrzyn

      CEO, Transfyr

      Xiaowei Zhuang

      Xiaowei Zhuang

      Howard Hughes Medical Institute; David B. Arnold Jr. Professor of Science; Professor of Chemistry, Chemical Biology & Physics, Harvard University

      See who spoke in the 2022 edition
      Register for the 2023 edition
      Group 705

      TOP SCIENTISTS & KOL

      Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

      PAST SPEAKERS
      Group 721

      PREVIOUS DEBATES

      Watch continuous debates on the biggest challenges facing human health worldwide

      WATCH THE DEBATES